ios 11212 has been researched along with Aura in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abrosimov, IIu; Karpova, MN; Kryzhanovskiĭ, GN; Lakinina, MV; Pankov, OIu | 1 |
| Dubur, GIa; Germane, SK; Glebov, RN; Karpova, MN; Klusha, VE; Pankov, OIu | 1 |
2 other study(ies) available for ios 11212 and Aura
| Article | Year |
|---|---|
[Anticonvulsant activity of sodium valproate and various calcium antagonists during their combined use in mice].
Topics: Animals; Anticonvulsants; Calcium Channel Blockers; Dihydropyridines; Diltiazem; Drug Therapy, Combination; Epilepsy; Male; Mice; Nifedipine; Valproic Acid; Verapamil | 1993 |
[Anti-epileptic effect of the new calcium channel blocker IOS-1.1212].
Topics: Animals; Anticonvulsants; Calcium Channel Blockers; Dihydropyridines; Epilepsy; Male; Penicillins; Pentylenetetrazole; Rats; Rats, Inbred Strains; Strychnine | 1991 |